Genome-wide association analysis reveals insights into the molecular etiology of dilated cardiomyopathy
Event: ESC Congress 2024
Topic: Cardiomyopathies
Session: Young Investigator Award Session in Population Science, Genetics and Epidemiology
Polygenic risk score for hypertrophic cardiomyopathy predicts population disease risk, penetrance in sarcomeric rare variant carriers and survival in cases
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Young Investigator Awards Session in Heart Failure
Cardiovascular outcomes with the incretin-based therapies GLP-1 agonists and DPP-4 inhibitors in type 2 diabetes participants with and without heart failure
Event: Heart Failure 2018
Topic: Diabetes and the Heart
Session: Moderated Poster session 3 - Novel treatment
Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in diabetics with cardiovascular disease or risk: a systematic review and meta-analysis of 13,395 patients
Event: ESC Congress 2017
Topic: Diabetes, dysglycaemia and metabolic syndrome
Session: Diabetes mellitus: from "omics to complications"
Effect of drug treatment on quality of life in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomised controlled trials
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: HFpEF - Heart failure with preserved ejection fraction
Session: HFpEF - Heart failure with preserved ejection fraction
Reporting quality of randomised controlled trials investigating efficacy of pharmacological therapies for heart failure with preserved ejection fraction
Event: HEART FAILURE 2016
Topic: HFpEF - Heart failure with preserved ejection fraction
Session: HFpEF - Heart failure with preserved ejection fraction
